Betamethasone And Neomycine

Product/Composition:- Betamethasone And Neomycine
Strength:- 0.1% + 0.5%
Form:- Drops
Packaging:- 5ml
Therapeutic use:- Eye and Ear Drops
Package Insert/Leaflet:- Available upon request
Inquire About Betamethasone And Neomycine
Inquiry in product detail page

We are a 100% export-oriented company and do not engage in domestic sales within India.

Introduction

We are a WHO-GMP certified pharmaceutical exporter supplying Betamethasone and Neomycin Eye and Ear Drops finished dosage formulations to importers and distributors across Africa, Southeast Asia, and the Middle East & CIS.

This combination formulation of Betamethasone (a synthetic corticosteroid) with Neomycin (an aminoglycoside antibiotic)  is manufactured as a sterile ophthalmic and otic drop, optimized for accurate dose delivery, ocular/aural tolerability, and patient compliance across topical anti-inflammatory and anti-infective therapy.

Every shipment is backed by a complete regulatory dossier, enabling fast-track market authorization and MOH registration in your country.

Product Overview Table

FieldDetails
Product NameBetamethasone and Neomycin Eye and Ear Drops
INN / Generic NameBetamethasone Sodium Phosphate + Neomycin Sulphate
Therapeutic ClassCorticosteroid + Aminoglycoside Antibiotic Combination (Ophthalmic/Otic)
IndicationsSteroid-responsive inflammatory conditions of the eye and ear with associated or suspected bacterial infection (e.g. conjunctivitis, blepharitis, otitis externa)
API QualityManufactured using DMF-grade Betamethasone Sodium Phosphate and Neomycin Sulphate
Pharmacopoeial StandardBP / USP / IP (confirm applicable standard per buyer requirement)
Available StrengthsBetamethasone 0.1% w/v + Neomycin 0.5% w/v
Dosage FormSterile Eye and Ear Drops (multi-dose dropper bottle)
Shelf Life24 – 36 Months (unopened); in-use period per label after first opening
StorageStore below 25°C, protect from light; discard as per in-use shelf life after opening
Manufacturing FacilityWHO-GMP Certified Facility – dedicated sterile ophthalmic/otic manufacturing line
Dossier AvailableYes, CTD / ACTD / eCTD format
Regulatory DocumentsCoA, CoPP, FSC, MOA, GMP Certificate, Stability Data
Markets ServedAfrica, Southeast Asia, Latin America, Middle East & CIS

Product Variant, Dosage Form & Strength

Betamethasone and Neomycin Eye and Ear Drops (0.1% + 0.5% w/v)

Sterile multi-dose eye and ear drop for combined anti-inflammatory and anti-infective topical therapy

Key markets: Africa, Middle East, CIS, and Southeast Asian retail pharmacy and hospital channels

Keyword target: Betamethasone Neomycin eye drops exporter, Betamethasone Neomycin ear drops supplier

Pharmacopoeial Compliance

BP (British Pharmacopoeia) –  Commonwealth, African, Middle East markets

USP (United States Pharmacopeia) – LATAM and global reference

IP (Indian Pharmacopoeia) – available on request

Regulatory & Dossier Support

Dossier Availability

CTD (Common Technical Document) – ICH-aligned and most regulated markets

ACTD (ASEAN Common Technical Dossier) – Philippines, Vietnam, Myanmar, Indonesia, Cambodia

eCTD (Electronic CTD) – for markets requiring electronic submissions

Country-specific dossier customization available on request

Dossier includes: Quality Module (Module 3), Safety & Efficacy summaries as applicable.

Sterility & Preservative Efficacy

As a sterile topical ophthalmic/otic formulation, Betamethasone and Neomycin Eye and Ear Drops is manufactured and tested to sterility and preservative-efficacy specifications rather than oral bioequivalence.

Preservative efficacy and sterility test data available on request to support regulated-market dossier submissions

Drug Master File (DMF)

API Drug Master File (DMF) references available for both Betamethasone Sodium Phosphate and Neomycin Sulphate, for cross-referencing in the buyer’s regulatory dossier

Helps reduce registration timelines in the importing country

CDSCO / Indian DMF available – reference acceptable for many markets

Manufacturing Compliance

WHO-GMP certified manufacturing facility

Site Master File (SMF) available for regulatory submissions

Facility audit-ready; inspection reports available on NDA basis

Dedicated sterile ophthalmic/otic manufacturing suite with aseptic filling – ensures sterility and particulate-free drop formulation.

Compliant with: NAFDAC (Nigeria), PPB (Kenya), TFDA (Tanzania).

Complete Documentation Package (Per Shipment)

DocumentPurpose
Certificate of Analysis (CoA)Confirms product quality against specifications
Certificate of Pharmaceutical Product (CoPP / CPP)Required for MOH registration in most countries
Free Sale Certificate (FSC)Confirms product is freely sold in country of manufacture
Method of Analysis (MOA)Lab testing methodology — required for dossier
GMP CertificateConfirms manufacturing facility compliance
Stability DataReal-time and accelerated — ICH Zone IVb for tropical markets
Batch Manufacturing Records (BMR)Available on request (NDA basis)
Excipient DeclarationsFor all inactive ingredients used

Clinical Indications & Therapeutic Information

Betamethasone and Neomycin Eye and Ear Drops combines a corticosteroid with an aminoglycoside antibiotic for topical use in the eye and ear.

Key indications: steroid-responsive inflammatory conditions of the eye (e.g. allergic/inflammatory conjunctivitis, blepharitis) and ear (e.g. otitis externa) with associated or suspected bacterial infection

Dosage and duration vary based on the site and severity of the condition – prescriber-guided

Manufactured in a dedicated sterile ophthalmic/otic facility, ensuring a particulate-free, preservative-validated formulation – a critical safety point for regulated-market buyers

High market demand in regions with significant burden of ocular and otic infections, including Africa, the Middle East, and Southeast Asia, driving consistent retail and institutional procurement volumes

Target Export Markets

Africa

Nigeria, Kenya, Tanzania, Ghana, Uganda, Ethiopia, Zambia, Cameroon, Côte d’Ivoire.

Focus: FSC, NAFDAC registration support (Nigeria), PPB (Kenya), TFDA (Tanzania), PCPB (Ghana)

Language: English, French labeling available for Francophone Africa

Southeast Asia

Philippines, Vietnam, Myanmar, Cambodia, Indonesia, Bangladesh

Focus: ACTD dossier format  mandatory for ASEAN market registrations

Stability: Tropical formulations (ICH Zone IVb) – critical for this climate region

Latin America (LATAM)

Colombia, Peru, Ecuador, Bolivia, Guatemala, Honduras

Focus: Spanish labeling, USP pharmacopoeial standard preferred

Dossier: CTD format with local regulatory adaptation support

Middle East & CIS

Iraq, Yemen, Uzbekistan, Kazakhstan, Kyrgyzstan

Focus: GMP Certificate and CoPP are primary registration requirements

Language: Arabic and Russian labeling available on request

Export Packaging & Supply Chain

Primary Packaging Options

Dosage FormPackaging Options
Eye and Ear Drops5 mL / 10 mL LDPE dropper bottle with tamper-evident cap, individually cartoned
Bulk / Institutional SupplyBulk pack for hospital/institutional procurement available on request

Labeling & Customization

Private label manufacturing available with custom brand name and artwork

Multi-lingual labeling: English, French, Spanish, Portuguese, Arabic, Russian

Country-specific labeling compliance: NAFDAC text, KEBS, local registration number fields

Logistics & Supply

Incoterms: FOB, CIF, CFR, EXW – as per buyer requirement

Shipment lead time: 45 to 60 Days from order confirmation

Experienced in shipping to Africa, CIS, LATAM, and Southeast Asia

Why Source Betamethasone and Neomycin Eye and Ear Drops From Us?

WHO-GMP Certified Manufacturing: All formulations are manufactured under WHO-GMP standards in a dedicated sterile ophthalmic/otic facility. Audit-ready; GMP certificates and SMF available on request.

Complete Dossier for 100+ Countries  CTD, ACTD, and eCTD dossiers pre-prepared. Reduces your market authorization timeline. Country-specific customization on request.

Validated Sterility & Preservative Efficacy  Full sterility assurance and preservative-efficacy data available to support your dossier submission.

Private Label & Custom Packaging  MOQ-based private labeling with your brand name, artwork, multilingual labeling, and country-specific regulatory compliance.

Competitive Ex-Works Pricing  Direct manufacturer pricing with no middlemen. Volume-based pricing tiers available for distributors and government tenders.

End-to-End Regulatory Support: From CoA to CoPP to FSC, all export documentation handled. Dedicated regulatory team for MOH registration guidance.

Frequently Asked Questions (FAQ)

Q1. Do you provide a dossier for Betamethasone and Neomycin Eye and Ear Drops?

Yes. We provide complete dossiers in CTD, ACTD, and eCTD formats for Betamethasone and Neomycin Eye and Ear Drops. The dossier includes Module 3 quality documentation, stability data (ICH Zone IVb for tropical climates), sterility and preservative-efficacy references, and full site information. Country-specific customization and regulatory guidance are available for your MOH submission.

Q2. Is your Betamethasone and Neomycin Eye and Ear Drops manufactured in a dedicated/controlled facility?

Yes. Our Betamethasone and Neomycin Eye and Ear Drops are manufactured in a dedicated sterile ophthalmic/otic manufacturing suite under aseptic filling conditions. This is fully documented in our Site Master File (SMF), available for regulatory submissions.

Q3. Which pharmacopoeial standard do your Betamethasone and Neomycin Eye and Ear Drops comply with: BP, USP, or IP?

Our Betamethasone and Neomycin Eye and Ear Drops are available compliant with BP / USP / IP. Please specify your market requirement at the time of inquiry, and we will confirm the applicable standard for your order.

Q4. Can you supply Betamethasone and Neomycin Eye and Ear Drops under our private label?

Yes, we offer private label manufacturing for Betamethasone and Neomycin Eye and Ear Drops. We handle packaging artwork, multilingual labeling (English, French, Spanish, Portuguese, Arabic), and country-specific regulatory label compliance.

Q5. What is the MOQ for Betamethasone and Neomycin Eye and Ear Drops export?

MOQ varies by pack size. Please contact our export team with your product specification, target market, and estimated volume requirement for a tailored quotation and lead time confirmation.

Q6. Which countries do you export Betamethasone and Neomycin Eye and Ear Drops to?

We currently export to 40+ countries across Africa, Southeast Asia, Latin America, and the Middle East & CIS. Our regulatory team provides country-specific registration support for each market.

Q7. What documents do you provide with each Betamethasone and Neomycin Eye and Ear Drops shipment?

Standard export documentation includes: Certificate of Analysis (CoA), Certificate of Pharmaceutical Product (CoPP), Free Sale Certificate (FSC), Method of Analysis (MOA), GMP Certificate, Packing List, Commercial Invoice, and Bill of Lading. Additional documents (BMR, Stability Reports) available on request.

Q8. What is the in-use shelf life of Betamethasone and Neomycin Eye and Ear Drops after opening the bottle?

As with most multi-dose sterile drop formulations, an in-use discard period applies after first opening to maintain sterility and preservative efficacy.